Javascript must be enabled to continue!
Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity
View through CrossRef
Gastroenteropancreatic (GEP) neuroendocrine carcinomas (NECs) and mixed adenoneuroendocrine carcinomas (MANECs) are heterogeneous neoplasms characterized by poor outcome. Microsatellite instability (MSI) has recently been found in colorectal NECs showing a better prognosis than expected. However, the frequency of MSI in a large series of GEP-NEC/MANECs is still unknown. In this work, we investigated the incidence of MSI in GEP-NEC/MANECs and characterized their clinicopathologic and molecular features. MSI analysis and immunohistochemistry for mismatch repair proteins (MLH1, MSH2, MSH6 and PMS2) were performed in 89 GEP-NEC/MANECs (six esophageal, 77 gastrointestinal, three pancreatic, and three of the gallbladder). Methylation of 34 genes was studied by methylation-specific multiplex ligation probe amplification. Mutation analysis of BRAF and KRAS was assessed by PCR-pyrosequencing analysis. MSI was observed in 11 NEC/MANECs (12.4%): seven intestinal and four gastric. All but two MSI-cases showed MLH1 methylation and loss of MLH1 protein. The remaining two MSI-cancers showed lack of MSH2 or PMS2 immunohistochemical expression. MSI-NEC/MANECs showed higher methylation levels than microsatellite stable NEC/MANECs (40.6% vs 20.2% methylated genes respectively, P<0.001). BRAF mutation was detected in six out of 88 cases (7%) and KRAS mutation was identified in 15 cases (17%). BRAF mutation was associated with MSI (P<0.0008), while KRAS status did not correlate with any clinicopathologic or molecular feature. Vascular invasion (P=0.0003) and MSI (P=0.0084) were identified as the only independent prognostic factors in multivariate analysis. We conclude that MSI identifies a subset of gastric and intestinal NEC/MANECs with distinct biology and better prognosis. MSI-NEC/MANECs resemble MSI-gastrointestinal adenocarcinomas for frequency, molecular profile and pathogenetic mechanisms.
Title: Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity
Description:
Gastroenteropancreatic (GEP) neuroendocrine carcinomas (NECs) and mixed adenoneuroendocrine carcinomas (MANECs) are heterogeneous neoplasms characterized by poor outcome.
Microsatellite instability (MSI) has recently been found in colorectal NECs showing a better prognosis than expected.
However, the frequency of MSI in a large series of GEP-NEC/MANECs is still unknown.
In this work, we investigated the incidence of MSI in GEP-NEC/MANECs and characterized their clinicopathologic and molecular features.
MSI analysis and immunohistochemistry for mismatch repair proteins (MLH1, MSH2, MSH6 and PMS2) were performed in 89 GEP-NEC/MANECs (six esophageal, 77 gastrointestinal, three pancreatic, and three of the gallbladder).
Methylation of 34 genes was studied by methylation-specific multiplex ligation probe amplification.
Mutation analysis of BRAF and KRAS was assessed by PCR-pyrosequencing analysis.
MSI was observed in 11 NEC/MANECs (12.
4%): seven intestinal and four gastric.
All but two MSI-cases showed MLH1 methylation and loss of MLH1 protein.
The remaining two MSI-cancers showed lack of MSH2 or PMS2 immunohistochemical expression.
MSI-NEC/MANECs showed higher methylation levels than microsatellite stable NEC/MANECs (40.
6% vs 20.
2% methylated genes respectively, P<0.
001).
BRAF mutation was detected in six out of 88 cases (7%) and KRAS mutation was identified in 15 cases (17%).
BRAF mutation was associated with MSI (P<0.
0008), while KRAS status did not correlate with any clinicopathologic or molecular feature.
Vascular invasion (P=0.
0003) and MSI (P=0.
0084) were identified as the only independent prognostic factors in multivariate analysis.
We conclude that MSI identifies a subset of gastric and intestinal NEC/MANECs with distinct biology and better prognosis.
MSI-NEC/MANECs resemble MSI-gastrointestinal adenocarcinomas for frequency, molecular profile and pathogenetic mechanisms.
Related Results
Abstract 2728: Correlation of p62/ubiquitin IHC expression with clinicopathologic outcome in gastrointestinal carcinomas
Abstract 2728: Correlation of p62/ubiquitin IHC expression with clinicopathologic outcome in gastrointestinal carcinomas
Abstract
Background:P62 and ubiquitin are small regulatory proteins demonstrated to have implications in the prognosis and survival of various malignancies including...
Diagnostic Utility of Orthopedia Homeobox (OTP) in Pulmonary Carcinoid Tumors
Diagnostic Utility of Orthopedia Homeobox (OTP) in Pulmonary Carcinoid Tumors
Recently, Orthopedia Homeobox (OTP) was described as a prognostic marker for pulmonary carcinoid tumors; however, little is known about the function and distribution pattern of thi...
Immunohistochemistry in ocular carcinomas
Immunohistochemistry in ocular carcinomas
Background: The distinction between ocular sebaceous carcinoma, poorly differentiated ocular squamous cell carcinoma and ocular basal cell carcinoma can be challenging. An appropr...
INSM1 expression in neuroendocrine tumors in a tertiary care hospital
INSM1 expression in neuroendocrine tumors in a tertiary care hospital
ABSTRACT
Aim:
Neuroendocrine tumors are heterogenous group of neoplasms that includes benign and malignant tumors that originate from neuroendocr...
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Abstract
Introduction
The short half-life of standard factor VIII (FVIII) products means that frequent injections (3 to 4 times/week) are needed for e...
Tumor Characteristics and Clinical Outcome of Tubular and Mucinous Breast Carcinomas
Tumor Characteristics and Clinical Outcome of Tubular and Mucinous Breast Carcinomas
PURPOSE: To comprehensively characterize the clinical and biologic features of tubular and mucinous carcinomas in a large cohort of patients and to relate this to clinical outcome ...
Abstract 3182: Tobacco smoke induces pulmonary neuroendocrine alterations in vivo
Abstract 3182: Tobacco smoke induces pulmonary neuroendocrine alterations in vivo
Abstract
Tobacco smoke is the leading cause of lung cancer. High-grade malignant pulmonary neuroendocrine tumors, including small cell lung cancers (SCLCs) and large...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

